https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / J Transl Med 2007 Apr;5:19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / J Transl Med 2007 Apr;5:192007-04-20 00:00:002019-02-15 09:19:42Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-292007-04-19 00:00:002019-02-15 08:48:10DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-18 / Cancer Immunol. Immunother. 2007 Oct;56(10):1597-604
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-18 / Cancer Immunol. Immunother. 2007 Oct;56(10):1597-6042007-04-18 00:00:002019-02-15 08:38:11Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-362007-04-10 00:00:002019-02-15 09:24:05Immunology and immunotherapy approaches for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-306
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-3062007-04-04 00:00:002019-02-15 08:37:28Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-342007-04-01 00:00:002019-02-15 08:59:47Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-452007-04-01 00:00:002019-02-15 08:59:50Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-482007-04-01 00:00:002019-02-15 08:59:52Dendritic cell-based active specific immunotherapy for malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Prostate 2007 Apr;67(5):500-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Prostate 2007 Apr;67(5):500-82007-04-01 00:00:002019-02-15 09:24:10Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells–a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-52007-04-01 00:00:002019-02-15 09:22:08In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV
